2023
DOI: 10.3389/fcvm.2022.1109445
|View full text |Cite
|
Sign up to set email alerts
|

Mechanism of homocysteine-mediated endothelial injury and its consequences for atherosclerosis

Abstract: Homocysteine (Hcy) is an intermediate amino acid formed during the conversion from methionine to cysteine. When the fasting plasma Hcy level is higher than 15 μmol/L, it is considered as hyperhomocysteinemia (HHcy). The vascular endothelium is an important barrier to vascular homeostasis, and its impairment is the initiation of atherosclerosis (AS). HHcy is an important risk factor for AS, which can promote the development of AS and the occurrence of cardiovascular events, and Hcy damage to the endothelium is … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
21
0
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 33 publications
(23 citation statements)
references
References 136 publications
1
21
0
1
Order By: Relevance
“…Homocysteine was observed as a specifically perturbed metabolite in female mice at the 1-month time point. Homocysteine has been implicated in oxidative stress and has been found to correlate with cardiovascular disease [42][43][44]. Altogether, our findings suggest that sex plays a significant role in the response to IR.…”
Section: Discussionsupporting
confidence: 61%
“…Homocysteine was observed as a specifically perturbed metabolite in female mice at the 1-month time point. Homocysteine has been implicated in oxidative stress and has been found to correlate with cardiovascular disease [42][43][44]. Altogether, our findings suggest that sex plays a significant role in the response to IR.…”
Section: Discussionsupporting
confidence: 61%
“…Numerous other biomarkers have also been shown to increase in atherosclerosis. Elevated homocysteine levels (>12 μmol/L) have been shown to predict the progression of coronary plaque burden [ 100 ]. Furthermore, plasma amyloid-β (1–40) (Aβ40) has been associated with the presence of subclinical CAD in individuals without clinically overt CAD [ 101 , 102 ], arterial stiffness progression in young healthy individuals, as well as with cardiovascular mortality and MACE in patients with CAD [ 103 ].…”
Section: Identifying the “Vulnerable Patient”mentioning
confidence: 99%
“…Agonist sensitivity (pEC50) and % maximum response (Rmax) of endothelium-dependent vasodilator, acetylcholine and endothelium-independent vasodilator sodium nitroprusside (SNP), in isolated aorta from SD rats treated with different concentration of Hcy (100 µM, 300 µM, 500 µM), 500 µM Hcy cotreated with TQ (0.1 µM, 1 µM, and 10 µM), 20 Homocysteine has been reported to reduce the endothelial cells viability during endothelial cells dysfunction [34][35][36]. Figure 2a shows HUVECS treated with Hcy has a reduction in cell viability in a concentration-dependent manner compared to control, with 10 mM of Hcy being the most effective concentration that caused apoptosis compared to control.…”
Section: Tablementioning
confidence: 99%